Medicine Matters
Shankar and Colleagues Describe Drug to Reduce Fatty Liver Disease
Kripa Shankar, Ph.D., an Instructor in the Hypothalamic Research Center, and colleagues have described the effects of a new drug compound on fatty liver disease and obesity in mice.
Zigman Lab Expands Understanding of Ghrelin’s Impact on Islet Physiology
Jeffrey Zigman, M.D., Ph.D., a Professor in the Center for Hypothalamic Research, explains his team’s findings.
CMRU Recognized by Area Nonprofit for Team Excellence
Members of the Cardiometabolic Research Unit Provide Health Screenings to Vulnerable Population
The Utopia of Rules: On Technology, Stupidity, and the Secret Joys of Bureaucracy
A brief synopsis by Salahuddin “Dino” Kazi, M.D.
Burstein and Colleagues Advance Understanding of Complex Molecular Process
Ezra Burstein, M.D., Ph.D., a Professor and Chief of Digestive and Liver Diseases, and colleagues recently published the results of an investigation into the molecular organization of essential regulators of endosomal recycling, a process required for normal functioning of all cells.
Hidden Potential: The Science of Achieving Greater Things
Adam Grant writes about organizational psychology and seeks and interprets natural and laboratory evidence to unlock new ways of understanding the human condition.
Zigman Lab Demonstrates Effects of Ghrelin Reduction on Pancreatic Islets
Jeffrey Zigman, M.D., Ph.D., a Professor in Center for Hypothalamic Research, explains his team’s findings.